期刊文献+

植入型心律转复除颤器不恰当放电的临床分析

Clinical analysis of inappropriate shock of implantable cardioverter defibrillators
原文传递
导出
摘要 目的分析植入型心律转复除颤器(ICD)不恰当放电发生情况及常见原因。方法2001年11月至2007年10月植入ICD并长期随访的43例患者。通过定期随访查询ICD中存储的事件信息,根据腔内电图判断事件是否为不恰当放电。结果43例患者中有7例发生了96次不恰当放电。6例患者是室上性心动过速引起,1例是干扰引起。5例患者第1次不恰当放电发生在植入ICD后1年内。植入ICD前有心房颤动(房颤)病史是发生不恰当放电的独立预测因子。结论植入ICD前有房颤病史的患者较易出现不恰当放电,临床应多予以重视。 Objective Implantable cardioverter defibrillator (ICD) can effectively treat life- threatening ventricular arrhythmias. The most common side effect is inappropriate discharge. This study analyzes the incidence and causes of inappropriate discharges of ICD in our hospital. Methods Forty-three patients implanted with ICD in our hospital from November 2001 to October 2007 were involved in our study. Patients were followed-up regularly. All episodes recorded and stored in the ICD were analyzed. Results Seven of the 43 patients underwent ninety-six inappropriate discharges. Inappropriate discharges in six patients were caused by supraventricular tachyarrhythmias (SVT). In one patient the discharge was caused by noise. Most inappropriate discharges occurred in the first year after implantation. The history of atrial fibrillation before implantation is an independent predictor of inappropriate discharges. Conclusions The incidence of inappropriate discharge is 16. 3% in our study and the most common cause is SVT. Most inappropriate discharges occur in the first year after implantation. Patients with atrial fibrillation history have a higher risk of inappropriate discharges.
出处 《中华内科杂志》 CAS CSCD 北大核心 2009年第1期28-30,共3页 Chinese Journal of Internal Medicine
基金 基金项目:广东省科技计划(20078031508007) 广州市科技计划(200723.E0111)
关键词 除颤器 植入型 猝死 心脏 电抗休克 Defibrillator,impantable Death, sudden,cardiac Electric countershock
  • 相关文献

参考文献14

  • 1Exner DV, Pinski SL, Wyse DG, et al. Antiarrhythmics Versus Implantable Defibrillators. Electrical storm presages nonsudden death : the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation ,2001,103:2066-2071.
  • 2Mushlin AI, Hall W J, Zwanziger J, et al. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. Circulation, 1998:2129-2135.
  • 3Korte T, Jung W, Spehl S, et al. Incidence of ICD lead related complications during long-term follow-up : comparison of epicardial and endocardial electrode systems. Pacing Clin Electrophysiol, 1995,18:2053-2061.
  • 4王方正,张澍,任自文,郭继鸿,胡大一,陈新,中华医学会心电生理和起搏分会及中国生物医学工程学会心脏起搏与电生理分会ICD专家工作组.植入型心律转复除颤器治疗的适应证[J].中华心律失常学杂志,2002,6(4):198-206. 被引量:29
  • 5Hurst TM, Hinrichs M, Breidenbach C, et al. Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. J Am Coll Cardiol, 1999,34:402408.
  • 6陈柯萍,陈若菡,王方正,华伟,张澍.植入型心律转复除颤器不适当识别和治疗的发生率及常见原因[J].中华心律失常学杂志,2006,10(6):409-413. 被引量:15
  • 7Nanthakumar K, Dorian P, Paquette M, et al. Is inappropriate implantable defibrillator shock therapy predictable? J Int Cardiac, 2003,8:215-220.
  • 8Stuber T, Eigenmann C, Delacretaz E. Inappropriate interventions during the long-term follow-up of patients with an implantable defibrillator. Swiss Med Wkly,2007,137:228-233.
  • 9Theuns DA, Klootwijk AP, Simoons ML, et al. Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathy. Am J Cardiol,2005,95 : 271-274.
  • 10Rosenqvist M, Beyer T, Block M, et al. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators. Circulation, 1998,98:663-670.

二级参考文献75

  • 1Mower MM, Swerdlow C, Mandel WJ, et al. Use of the automatic implantable cardiovertor defibrillators in the treatment of malignant ventricular tachyarrhythmias. In: Willium J Mander, ed. Cardiac Arrhythmias: Their Mechanism, Diagnosis, and Management. 3rd ed. Philadelphia: J B Lippingcott Company, 1995.
  • 2Mirowski M, Mower MM, Staewen WS, et al. Standby automatic defibrillator: An approach to prevention of sudden coronary death. Arch Intern Med, 1970, 126: 150161.
  • 3Wichter T, Block M, Bocker D, et al. Cardioverter defibrillator therapy in a high risk subgroup of patients with arrhythmogenic right ventricular disease. J Am Coll Cardiol, 1993, 21:127A.
  • 4Maron BJ, Fananapazir L. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation, 1992, 85 (Suppl Ⅰ ) :157-163.
  • 5Kaminer SJ, Pickoff AS, Dunnigan A, et al. Cardiomyopathy and the use of implanted cardiac-defibrillators in children. Pacing Clin Electrophysiol, 1990, 13:593597.
  • 6Brugada P, Brugada J. Right bundle-branch block, persistent ST segment elevation and sundden cardiac death:distinct clinical and electrocardiography syndrom. A multicenter report. J Am Coll Cardiol, 1992, 20: 13911396.
  • 7Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST segment elevation in lead V1, through V3:a marker for sudden death in patients without demonstrable structural heart disease. Circulation, 1998, 47: 457460.
  • 8Brugada P, Brugada R, Brugada J. Sudden death in patients and relatives with the syndrome of right bundle branch block. ST segment elevation in the precordial leads V1 to V3 and sudden death. Eur Heart J, 2000, 21:321-326.
  • 9Atratashi H, Dgawa S, Harumi K, et al. Characteristic of patients with right bundle-branch block and ST segment elevation in right precordial leads. Am J Cardiol, 1996,78: 581-583.
  • 10Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implantable automatic defibrillator in human beings. N Engl J Med,1980, 303: 322-324.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部